Sign in to add mentor
Bert W. O'Malley grad student 1987 Baylor College of Medicine
 (Analysis of the molecular structure of the vitamin D3 receptor.)


Sign in to add trainee
Caroline E. Connor grad student 2000 Duke
Julianne M. Hall grad student 2000 Duke
Maria R. Hamilton grad student 2000 Duke
Ashini L. Wijayaratne grad student 2000 Duke
Erin A. Kimbrel grad student 2002 Duke
Nora K. McGhee grad student 2006 Duke
Linda Grasfeder grad student 2007 Duke
Tianyu Li grad student 2007 Duke
Niharika B. Mettu grad student 2007 Duke
Andrea Sherk grad student 2007 Duke
Carolyn D. DuSell grad student 2009 Duke
Hilary E. Wade grad student 2009 Duke
Sonja N. Brun grad student 2014 Duke
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Artham S, Chang CY, McDonnell DP. (2022) Eosinophilia in cancer and its regulation by sex hormones. Trends in Endocrinology and Metabolism: Tem. 34: 5-20
Tsuji J, Li T, Grinshpun A, et al. (2022) Clinical Efficacy and Whole Exome Sequencing of Liquid Biopsies in a Phase IB/II study of Bazedoxifene and Palbociclib in Hormone Receptor-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Sammeta VR, Norris JD, Artham S, et al. (2022) A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-]pyrimidine Core. Acs Medicinal Chemistry Letters. 13: 1151-1158
Chakraborty B, Byemerwa J, Krebs T, et al. (2022) Estrogen receptor signaling in the immune system. Endocrine Reviews
Haines CN, Wardell SE, McDonnell DP. (2021) Current and emerging estrogen receptor-targeted therapies for the treatment of breast cancer. Essays in Biochemistry
Andreano KJ, Baker JG, Park S, et al. (2020) The dysregulated pharmacology of clinically relevant ESR1 mutants is normalized by ligand-activated WT receptor. Molecular Cancer Therapeutics
Chakraborty B, Bymerwa J, Baldi R, et al. (2020) Abstract A44: Pharmacologic targeting of estrogen receptor in melanoma to enhance antitumor immunity Cancer Immunology Research. 8
Cocce KJ, Jasper JS, Desautels TK, et al. (2019) The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Reports. 29: 889-903.e10
Wardell SE, Yllanes AP, Chao CA, et al. (2019) Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy. Breast Cancer Research and Treatment
Park S, Safi R, Liu X, et al. (2019) Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathways as Targetable Vulnerabilities in Breast Cancer. Cell Reports. 27: 3587-3601.e4
See more...